Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
J Geriatr Oncol
; 13(5): 582-593, 2022 06.
Article
en En
| MEDLINE
| ID: mdl-35101364
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Calidad de Vida
/
Neoplasias de la Mama
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
J Geriatr Oncol
Año:
2022
Tipo del documento:
Article